Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Calls For More Tier 4 Restrictions As Hospitals Strain Under Covid

Tue, 29th Dec 2020 15:39

(Alliance News) - Pressure is growing for the expansion of the toughest coronavirus restrictions in the face of increasing strain on hospitals in England where the number of patients has surpassed the April peak of the first wave.

Health Secretary Matt Hancock is due to announce any changes to tier areas in a statement to the Commons on Wednesday.

An expert adviser to the government said national coronavirus restrictions are needed to prevent a "catastrophe" amid rising infections, and the head of an organisation representing health trusts said "as much of the country as possible" should go into the harshest Tier 4.

The debate over the reopening of schools after the Christmas break is also continuing, with scientists and school leaders suggesting a delay might be needed amid rising cases.

The government said it is "still planning for a staggered opening of schools" after Christmas but is keeping the approach under constant review,

Professor Andrew Hayward, of the government's New & Emerging Respiratory Virus Threats Advisory Group said he thinks schools will have to return "maybe a little bit later" and reopening would mean "we're going to have to have increased, strict restrictions in other areas of society to pay for that".

Fellow Nervtag member Neil Ferguson said there had been a "balancing act" since lockdown was initially eased to try to keep control of the virus while maintaining "some semblance of normal society" but that the new variant had made it more difficult.

He told BBC Radio 4's World At One programme: "Clearly nobody wants to keep schools shut. But if that's the only alternative to having exponentially growing numbers of hospitalisations, that may be required at least for a period."

Geoff Barton, general secretary of the Association of School & College Leaders, welcomed the government's plans for soldiers to offer remote support for testing in schools, but warned it is unlikely to be enough.

Hayward, professor of infectious diseases epidemiology at University College London, said widespread Tier 4 restrictions – or even higher – are likely to be needed as the country moves towards "near-lockdown".

He told BBC Radio 4's Today programme: "I think we are entering a very dangerous new phase of the pandemic and we're going to need decisive, early, national action to prevent a catastrophe in January and February."

Asked whether a national Tier 4 lockdown should be brought in, NHS Providers deputy chief executive Saffron Cordery told BBC Radio Five Live: "I think we need to see, yes, as much of the country as possible in Tier 4."

She said some trusts are reporting up to three times the number of Covid-19 patients as at the peak of the first wave.

NHS England Chief Executive Simon Stevens has warned that doctors and nurses are "back in the eye of the storm".

Figures from NHS England show there were 20,426 patients in NHS hospitals in England at 0800 GMT on Monday, compared with 18,974 on April 12.

Stevens said: "Many of us have lost family, friends, colleagues and – at a time of year when we would normally be celebrating – a lot of people are understandably feeling anxious, frustrated and tired.

"And now, again, we are back in the eye of the storm with a second wave of coronavirus sweeping Europe and, indeed, this country."

Stevens said there is a "chink of hope" in the various Covid-19 vaccines, with the Oxford/AstraZeneca PLC jab expected to be approved imminently by the Medicines & Healthcare products Regulatory Agency, according to reports.

On Tuesday, 90-year-old grandmother Margaret Keenan, who became the first person in the world to receive the Pfizer Inc vaccine earlier this month following its clinical approval, was given her second dose at Coventry's University Hospital.

The current vaccination target will have to be doubled to two million jabs a week to avoid a third wave of the virus, according to a projection from a London School of Hygiene & Tropical Medicine paper reported by the Telegraph.

Trusts in England were told in a letter just before Christmas to begin planning for the use of Nightingale hospitals, although concerns have been raised around staffing the sites.

One senior doctor said some trusts in London and the South East are considering the option of setting up tents outside hospitals to triage patients.

Emergency medicine consultant Simon Walsh said staff are working in "major incident mode" and called on the government to set out a "coherent plan" to get through the coming weeks.

Paramedics in London are receiving support from other ambulance services in the South as they receive up to 8,000 emergency 999 calls each day.

South Central Ambulance Service said it is "pre-warning" the military and fire service that paramedics may need help after an average increase of 10% in 999 calls over the Christmas period and a threefold rise in 111 calls, along with a 60%-70% increase in absence rates with staff symptomatic or self-isolating.

The government said a further 357 people had died within 28 days of testing positive for Covid-19 as of Monday, taking the UK total to 71,109.

The number of further lab-confirmed cases recorded in a single day in the UK also hit a new high of 41,385 at 9am on Monday, rising above 40,000 for the first time, according to Government figures.

The true number is likely to be higher because figures do not include information from Scotland and Northern Ireland, which did not report data between December 24 and 28.

It is not possible to make direct comparisons with the level of infection during the first wave of the virus, because mass testing was only introduced in the UK in May, but it has been estimated there may have been as many 100,000 cases a day at the peak in late March and early April.

More than six million people in east and south-east England went into the highest level of restrictions on Saturday, meaning 24 million – 43% of the population – are now affected.

Lockdown measures are also in place across the other three home nations, after mainland Scotland entered Level 4 restrictions from Saturday for three weeks, and a similar stay-at-home order is in place in Wales.

Northern Ireland has also entered a new six-week lockdown, and the first-week measures are the toughest yet, with a form of curfew in operation from 8pm, shops closed from that time and all indoor and outdoor gatherings prohibited until 6am.

source: PA

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.